Council of Governors Meeting Tim Bennett – Director of Finance and Steven Vaughan – Director of Operations &Performance July 2011

Key Performance Indicators Area of review Key Highlights In-month Rating Year to date Rating Year end projectio n Financial Summary  The Trust recorded a surplus of £258k against a planned surplus of £225k for June. The annual plan is to break even. Activity Activity in June was slightly below plan; however the Trust is anticipating delivering its activity plan in full by the end of the financial year. The Trust is measured against a range of performance indicators Including use of resources and quality of services provided

Governance Risk Rating Declaration of performance against healthcare targets and indicators for Q1 Target or Indicator (per Compliance Framework) ThresholdWeighting Annual Plan At Risk Q1Met/Not Met Clostridium Difficile -meeting the C.Diff objective as agreed1.0 NoAchieved MRSA - meeting the MRSA objective as agreed1.0 NoAchieved Cancer 31 day wait for second or subsequent treatment - surgery >94%1.0 No Achieved Cancer 31 day wait for second or subsequent treatment - drug treatments >98%1.0 No Cancer 31 day wait for second or subsequent treatment - radiotherapy >94%1.0 No Cancer 62 Day Waits for first treatment (from urgent GP referral) >85%1.0 NO Achieved Cancer 62 Day Waits for first treatment (from Consultant led screening service referral) >90%1.0 No Referral to treatment time, 95th percentile, admitted patients <23Wks1.0 NoAchieved Referral to treatment time, 95th percentile, non-admitted patients <18.3Wks1.0 NoAchieved Cancer 31 day wait from diagnosis to first treatment >96%0.5 NoAchieved Cancer 2 week (all cancers) >93%0.5 No Achieved Cancer 2 week (breast symptoms) >93%0.5 No A&E Clinical Quality- Total Time in A&E (95th percentile) <4Hrs0.5 No Not applicable until Q2 A&E Clinical Quality- Time to Initial Assessment (95th percentile) < 15 Mins0.5 Yes A&E Clinical Quality- Time to Treatment Decision (median) < 60 Mins0.5 Yes A&E Clinical Quality- Unplanned Re-attendance Rate <5%0.5 No A&E Clinical Quality- Left Without Being Seen Rate <5%0.5 Mo Stroke Indicator (TBC) ( If % spending 90% on a stroke unit ) TBC0.5 Yes Not applicable until Q2 Stroke Indicator (TBC) ( If % TIA seen/treated within 24 hours) TBC0.5 No Minimising delayed transfers of care <=7.5%1.0 NoAchieved Compliance with requirements regarding access to healthcare for people with a learning disability N/A0.5 NoAchieved

Governance risk ratings cont Target or Indicator (per Compliance Framework) ThresholdWeighting Annual Plan At Risk Q1Met/Not Met Explanation Risk of, or actual, failure to deliver mandatory services Yes/No 4.0 No CQC compliance action outstanding Yes/No 2.0 NoYes Immediate actions from the CQC review have been completed and the level of risk reduced significantly, the remaining actions are mostly sustainability actions being completed in the next few months CQC enforcement notice currently in effect Yes/No 4.0 No Moderate CQC concerns regarding the safety of healthcare provision Yes/No 1.0 No Major CQC concerns regarding the safety of healthcare provision Yes/No 2.0 No Unable to maintain, or certify, a minimum published CNST level of 1.0 or have in place appropriate alternative arrangements Yes/No 2.0 No Governance risk rating

Exceptions from CQC June 11report following visit in April 13 of 16 outcomes fully compliant with essential standards Some suggestions for further improvement to ensure sustainability- action plans in place Action plans for moderate concerns in outcomes 5 – Meeting Nutritional needs, 13 – Staffing on wards, 17 – complaints response times Immediate concerns were acted upon Outstanding actions are mostly about sustaining solutions for the future CQC stated high degree of confidence in action plans

More detailed information: Can be found on the Trust’s web-site via the following link: